Vestibular Caloric Stimulation and the Modulation of Pain in Fibromyalgia
Launched by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · Aug 9, 2021
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
This is an open label pilot study testing the potential therapeutic efficacy of vestibulocortical stimulation via cold water calorics in fibromyalgia. The trial will entail 6 weeks of total involvement for each participant including 3 weeks of active participation, with 4 weeks follow up: the irrigation happens at the beginning of week 2, so 4 weeks later is week 6.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 18 years old with ability to comprehend and consent to protocol.
- • Diagnosis of fibromyalgia by American College of Rheumatology (ACR) criteria (questionnaire).
- • At least a 4/10 baseline on the visual analogue pain scale (VAS).
- • Stable fibromyalgia medications for at least 4 weeks.
- • Owns or has access to a smart phone or computer to complete outcome measures.
- Exclusion Criteria:
- • Use of opioids
- • Otitis externa or media within the past six months.
- • Current ear pain with or without other symptoms of otitis externa.
- • History of tympanic membrane rupture or surgery.
- • Current pregnancy.
- • Inability to lay supine for 30 minutes.
- • Limited decision making capacity.
- • Engaged in litigation, currently or prior, related to FMS.
- • Inability to commute to clinic once.
- • Primary language not English.
- • Clinically significant or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise participation in the study
- • Treatment with the medication meclizine for vertigo
- • History of seizures
- • Diagnosis of bipolar disorder (treated or untreated)
About Icahn School Of Medicine At Mount Sinai
The Icahn School of Medicine at Mount Sinai is a premier academic institution located in New York City, renowned for its commitment to advancing medical research, education, and patient care. As a leading sponsor of clinical trials, the institution leverages its state-of-the-art facilities and multidisciplinary expertise to drive innovative research initiatives aimed at improving health outcomes. With a focus on translational medicine, the Icahn School of Medicine collaborates with a diverse network of researchers, clinicians, and industry partners to explore novel therapies and interventions across a wide range of medical disciplines. Its rigorous scientific approach and dedication to ethical standards position it as a trusted leader in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Ioannis Tassiulas, MD
Principal Investigator
Icahn School of Medicine at Mount Sinai
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials